Status:
TERMINATED
Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors
Lead Sponsor:
Dallas VA Medical Center
Conditions:
Cancer Recurrence
Solid Tumors
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, ove...
Detailed Description
Routine visits would include COLON:14 visits with cea and 6 CTs over a 5 year period plus PET/CT at last visit RECTAL: 14 visits with cea and 6 CTs and 4 procto exams over 5 year period plus PET/CT at...
Eligibility Criteria
Inclusion
- Completed primary therapy such that no disease is evident at the time of enrollment in the study
Exclusion
- Patients unable to consent
- Without diagnosis of colorectal cancer
- Non-small cell lung cancer or squamous cell cancer of the head and neck
- Unwilling or unable to participate in the assigned follow-up program
- Having a serum glucose at time of PET/CT greater than 180mg/dl
- Stage IV disease or with evidence of disease recurrence post treatment
- Who are not a candidate for further treatment should a recurrence of disease be identified
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00954148
Start Date
September 1 2009
End Date
June 1 2010
Last Update
June 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA North Texas Health Care System
Dallas, Texas, United States, 75216